ZA991641B - Treatment of viral disease in swine. - Google Patents

Treatment of viral disease in swine.

Info

Publication number
ZA991641B
ZA991641B ZA9901641A ZA991641A ZA991641B ZA 991641 B ZA991641 B ZA 991641B ZA 9901641 A ZA9901641 A ZA 9901641A ZA 991641 A ZA991641 A ZA 991641A ZA 991641 B ZA991641 B ZA 991641B
Authority
ZA
South Africa
Prior art keywords
swine
treatment
viral disease
viral
disease
Prior art date
Application number
ZA9901641A
Other languages
English (en)
Inventor
Gregory Alan Armbruster
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA991641B publication Critical patent/ZA991641B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
ZA9901641A 1998-03-02 1999-03-01 Treatment of viral disease in swine. ZA991641B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7646698P 1998-03-02 1998-03-02

Publications (1)

Publication Number Publication Date
ZA991641B true ZA991641B (en) 2000-09-01

Family

ID=22132217

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9901641A ZA991641B (en) 1998-03-02 1999-03-01 Treatment of viral disease in swine.

Country Status (16)

Country Link
US (1) US6034070A (da)
EP (1) EP0948967B1 (da)
JP (1) JP4555472B2 (da)
AT (1) ATE281173T1 (da)
AU (1) AU2979899A (da)
CA (1) CA2322327C (da)
CO (1) CO5080775A1 (da)
DE (1) DE69921530T2 (da)
DK (1) DK0948967T3 (da)
ES (1) ES2230802T3 (da)
MY (1) MY124071A (da)
PT (1) PT948967E (da)
SI (1) SI0948967T1 (da)
TW (1) TW565452B (da)
WO (1) WO1999044619A1 (da)
ZA (1) ZA991641B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506885B1 (en) * 2001-09-27 2003-01-14 The United States Of America As Represented By The Secretary Of Agriculture Monoclonal antibodies to the drug tilmicosin and a method for detecting the same
JP4850390B2 (ja) * 2001-10-19 2012-01-11 アイデックス ラボラトリーズ インコーポレイテッド 薬理学的に活性な化合物の制御送達のための注射用組成物
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
ATE452896T1 (de) 2002-03-12 2010-01-15 Bristol Myers Squibb Co C3-cyanoepothilonderivate
US7282487B2 (en) * 2004-10-28 2007-10-16 Idexx Laboratories Method for treating bacterial infections in horses or pigs with tilmicosin
PL2089408T3 (pl) 2006-07-28 2012-03-30 Intervet Int Bv Sposób syntezy makrolidu
CN103288904B (zh) * 2013-06-28 2015-07-15 宁夏泰瑞制药股份有限公司 一种磷酸替米考星晶体的制备方法
CN103483406A (zh) * 2013-09-25 2014-01-01 宁夏泰瑞制药股份有限公司 一种磷酸替米考星的制备方法
CN103923141B (zh) * 2014-04-21 2016-04-27 西南大学 一种依托替米考星的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561147B2 (en) * 1982-09-13 1987-04-30 Eli Lilly And Company 20-amino macrolide antibiotics
US4820695A (en) * 1982-09-13 1989-04-11 Eli Lilly And Company C-20-dihydro-deoxy-(cyclic amino)-derivatives of macrolide antibiotics
US5574020A (en) * 1989-09-28 1996-11-12 Eli Lilly And Company Tilmicosin formulation
US5695766A (en) * 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
GB2289279B (en) * 1994-05-13 1998-09-16 Iberica Cyanamid Diagnostic kits and vaccines containing recombinant PRRSV proteins
ATE268783T1 (de) * 1995-03-14 2004-06-15 Akzo Nobel Nv Expression in der selben zelle von polypeptide vom schweinen reproduktiven und respiratorischen syndrom

Also Published As

Publication number Publication date
WO1999044619A1 (en) 1999-09-10
EP0948967A3 (en) 1999-10-20
MY124071A (en) 2006-06-30
CA2322327C (en) 2009-12-22
PT948967E (pt) 2005-02-28
CA2322327A1 (en) 1999-09-10
US6034070A (en) 2000-03-07
DK0948967T3 (da) 2005-02-14
ES2230802T3 (es) 2005-05-01
EP0948967B1 (en) 2004-11-03
SI0948967T1 (en) 2005-06-30
CO5080775A1 (es) 2001-09-25
AU2979899A (en) 1999-09-20
EP0948967A2 (en) 1999-10-13
DE69921530D1 (de) 2004-12-09
JP2002505294A (ja) 2002-02-19
ATE281173T1 (de) 2004-11-15
JP4555472B2 (ja) 2010-09-29
DE69921530T2 (de) 2005-10-27
TW565452B (en) 2003-12-11

Similar Documents

Publication Publication Date Title
CY2018020I1 (el) Θεραπεια της νοσου ρομρε
HK1033463A1 (en) 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
GB0025173D0 (en) Therapeutic agents
GB0005251D0 (en) Therapeutic compounds
ATE245641T1 (de) Antivirale pyrimidinderivate
ATE342728T1 (de) Zubereitung zur behandlung von einer neurologischen erkrankung
WO2002002518A3 (en) Compounds to treat alzheimer's disease
KR890701107A (ko) 알쯔하이머 병 치료용 화합물들
WO2002002520A8 (en) Compounds to treat alzheimer's disease
SE9604786D0 (sv) New compounds
EP0278174A3 (en) Use of fluticasone propionate in the treatment of bowel diseases
ZA967746B (en) Treatment of tinnitus using neuroprotective agents.
ES2191075T3 (es) 8-arilalquil- y 8-arilheteroalquil-5,11-dihidro-6h-dipirido-(3,2-b:2',3'-e)(1,4)diazepinas y su uso en la prevencion o tratamiento de infecciones por hiv.
NL960024I2 (nl) Farmaceutisch preparaat omvattend 3'-deoxythymidine-2'-een (3'-deoxy-2',3'-didehydrothymidine) voor de behandeling van met retrovirus besmette patiënten.
ZA991641B (en) Treatment of viral disease in swine.
BR0012921A (pt) Compostos calcilìticos
DE29820268U1 (de) Behandlungstisch für medizinische Zwecke
NO970185D0 (no) Anvendelse av (S)-adenosyl-L-metionin (SAMe) og dets fysiologisk kompatible salter for behandling av reperfusjonsskade utlöst av temporær-fokal-ischemi
IT216694Z2 (it) Manopola monouso, per l'igiene personale di pazienti in genere.
DK0459176T3 (da) Oligophosphater med antiviral virkning
WO1998044913A3 (en) Compositions containing mkc-442 in combination with other antiviral agents
ES2141330T3 (es) Monohidrato de (e)-2'-desoxi-2'-(fluorometileno)citidina.
LTIP1943A (en) Arylating agents, used in the treatment of cancerand disease caused by viral infection
DE68914886D1 (de) Mittel zur Behandlung von Raynaud's Krankheit.
EP0210099A3 (en) Use of n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulfamoylbenzamide in the treatment of parkinsons's disease